CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

lifesci partners coverage, page-3

  1. 550 Posts.
    News on diagnostic test is inconsequential.

    New NDA covers T315I mutation diagnostic test issues anyway.
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.